La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
ResMed Gestione
Gestione criteri di controllo 4/4
ResMed's Il CEO è Mick Farrell, nominato in Mar2013, e ha un mandato di 11.42 anni. la retribuzione annua totale è $ 13.87M, composta da 8.1% di stipendio e 91.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.32% delle azioni della società, per un valore di $ 106.65M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.4 anni e 8.8 anni.
Informazioni chiave
Mick Farrell
Amministratore delegato
US$13.9m
Compenso totale
| Percentuale dello stipendio del CEO | 8.1% |
| Mandato del CEO | 11.4yrs |
| Proprietà del CEO | 0.3% |
| Durata media del management | 3.4yrs |
| Durata media del Consiglio di amministrazione | 8.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
ResMed (NYSE:RMD) Is Increasing Its Dividend To $0.53
Aug 05
Does ResMed (NYSE:RMD) Have A Healthy Balance Sheet?
Jul 29Returns On Capital Are A Standout For ResMed (NYSE:RMD)
Jul 15ResMed: Asymmetrical Value Opportunity With High Prospect Of Re-Rating
Jul 03An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 33% Undervalued
Jul 02ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Apr 30Earnings Beat: ResMed Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 30ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear
Apr 18With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
Mar 22Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future
Mar 10An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued
Feb 12Why ResMed Is One Of My Top Picks In 2024
Jan 22A First Look At ResMed
Jan 09ResMed Inc.'s (NYSE:RMD) Share Price Could Signal Some Risk
Dec 20Why You Should Care About ResMed's (NYSE:RMD) Strong Returns On Capital
Dec 06Shareholders May Find It Hard To Justify Increasing ResMed Inc.'s (NYSE:RMD) CEO Compensation For Now
Nov 10Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 41%?
Nov 01ResMed: Weight-Loss Drug Worries Provide Buying Opportunity
Oct 28ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity
Sep 12ResMed Has Become A Steal (Rating Upgrade)
Aug 10ResMed's (NYSE:RMD) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 07ResMed (NYSE:RMD) Has Some Way To Go To Become A Multi-Bagger
Jul 30Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Jul 16Compound Your Wealth With ResMed
Jul 04A Look At The Fair Value Of ResMed Inc. (NYSE:RMD)
Jul 02We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26ResMed (NYSE:RMD) Could Be Struggling To Allocate Capital
Apr 24Here's Why ResMed (NYSE:RMD) Has Caught The Eye Of Investors
Apr 09A Look At The Intrinsic Value Of ResMed Inc. (NYSE:RMD)
Mar 26ResMed goes ex dividend tomorrow
Feb 07ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Feb 06Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$1b |
| Mar 31 2024 | n/a | n/a | US$958m |
| Dec 31 2023 | n/a | n/a | US$890m |
| Sep 30 2023 | n/a | n/a | US$907m |
| Jun 30 2023 | US$14m | US$1m | US$898m |
| Mar 31 2023 | n/a | n/a | US$863m |
| Dec 31 2022 | n/a | n/a | US$809m |
| Sep 30 2022 | n/a | n/a | US$786m |
| Jun 30 2022 | US$12m | US$1m | US$779m |
| Mar 31 2022 | n/a | n/a | US$779m |
| Dec 31 2021 | n/a | n/a | US$522m |
| Sep 30 2021 | n/a | n/a | US$500m |
| Jun 30 2021 | US$10m | US$1m | US$475m |
| Mar 31 2021 | n/a | n/a | US$457m |
| Dec 31 2020 | n/a | n/a | US$699m |
| Sep 30 2020 | n/a | n/a | US$680m |
| Jun 30 2020 | US$10m | US$1m | US$622m |
| Mar 31 2020 | n/a | n/a | US$513m |
| Dec 31 2019 | n/a | n/a | US$455m |
| Sep 30 2019 | n/a | n/a | US$419m |
| Jun 30 2019 | US$10m | US$967k | US$405m |
| Mar 31 2019 | n/a | n/a | US$446m |
| Dec 31 2018 | n/a | n/a | US$450m |
| Sep 30 2018 | n/a | n/a | US$335m |
| Jun 30 2018 | US$9m | US$934k | US$316m |
Compensazione vs Mercato: La retribuzione totale di Mick ($USD 13.87M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 13.21M ).
Compensazione vs guadagni: La retribuzione di Mick è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Mick Farrell (52 yo)
11.4yrs
Mandato
US$13,868,641
Compensazione
Mr. Michael J. Farrell, also known as Mick, BE, SM, MBA, served as Director of Fullbay, Inc. since May 2023 until 2023. He serves as Member of Advisory Board at Green Sun Medical, LLC. He serves as the Chi...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Chairman | 11.4yrs | US$13.87m | 0.32% $ 106.6m | |
| Founder | no data | US$680.27k | 0.060% $ 19.9m | |
| Chief Financial Officer | 18.6yrs | US$3.11m | 0.067% $ 22.3m | |
| Special Advisor | less than a year | US$6.67m | 0.18% $ 60.2m | |
| Chief Commercial Officer - SaaS | 2.5yrs | US$3.31m | 0.015% $ 5.0m | |
| Chief Investor Relations Officer | 1.3yrs | Nessun dato | Nessun dato | |
| Chief Legal Officer | 1.1yrs | Nessun dato | 0.0077% $ 2.6m | |
| Chief Compliance Officer | 6.6yrs | Nessun dato | Nessun dato | |
| Chief Marketing Officer | less than a year | Nessun dato | Nessun dato | |
| Chief People Officer | 3.4yrs | Nessun dato | Nessun dato | |
| Chief Strategy Officer | 9.7yrs | Nessun dato | Nessun dato | |
| Chief Product Officer | 8.3yrs | Nessun dato | 0.019% $ 6.3m |
3.4yrs
Durata media
57yo
Età media
Gestione esperta: Il team dirigenziale di RMD è considerato esperto (durata media dell'incarico 3.4 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Chairman | 11.4yrs | US$13.87m | 0.32% $ 106.6m | |
| Founder | 35.2yrs | US$680.27k | 0.060% $ 19.9m | |
| Independent Director | 19yrs | US$340.06k | 0.010% $ 3.4m | |
| Lead Independent Director | 19.6yrs | US$372.56k | 0.014% $ 4.7m | |
| Independent Non-Executive Director | 5.3yrs | US$320.06k | 0.0039% $ 1.3m | |
| Independent Director | 5.8yrs | US$320.06k | 0.0049% $ 1.6m | |
| Independent Director | 10.8yrs | US$360.06k | 0.010% $ 3.4m | |
| Independent Director | 6.8yrs | US$320.06k | 0.0052% $ 1.7m | |
| Independent Director | 2.8yrs | US$320.06k | 0.0014% $ 471.8k | |
| Independent Director | 2.8yrs | US$320.06k | 0.0014% $ 471.8k |
8.8yrs
Durata media
62yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di RMD sono considerati esperti (durata media dell'incarico 8.8 anni).